Cancer Journal

Article	Citations
Hepatocellular Carcinoma Genetic Classification	34
Theranostics in Neuroendocrine Tumors	34
Human Papillomavirus–Directed Therapeutics for Human Papillomavirus–Associated Oropharyngeal Cancer	31
Improving Equity in Cancer Care in the Face of a Public Health Emergency	23
Adoptive Cell Therapy for Advanced Solid Tumors	16
Concerns About Compounded Bioidentical Menopausal Hormone Therapy	14
Beyond the COVID-19 Pandemic	14
Menopausal Hormone Therapy and Breast Cancer	13
Is There a Role for Cellular Therapy in Chronic Lymphocytic Leukemia?	12
Circulating Biomarkers in Glioblastoma	11
Poly(ADP-Ribose) Polymerase Inhibition in Small Cell Lung Cancer	11
Autoimmune Cytopenia in CLL	10
Minimal Residual Disease in Multiple Myeloma	10
Cell Cycle Checkpoints p16 and p21—Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma	10
New Roles of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of Breast Cancer	9
The Clinical Value of Plasma Epstein-Barr Virus DNA as a Tumor Marker in Nasopharyngeal Carcinoma: Prognostic? Yes, But How Can We Best Use It?	9
The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors Resistance	9
Oncology Physician Workforce Diversity	8
The Potential for Selective Cyclin-Dependent Kinase 4/6 Inhibition in the Therapy for Head and Neck Squamous Cell Carcinoma	8
Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?	7
Evolution of Response-Based Radiotherapy for Hepatocellular Cancer	7
Updates in Classification of Myelodysplastic Syndrome	7
PET Imaging of Metabolism, Perfusion, and Hypoxia	7
Toxicities From Antibody-Drug Conjugates	7
Disparities in Gynecologic Cancers	7

Supportive Care for Patients With Myelodysplastic Syndromes	7
Radiopharmaceuticals for Cancer Diagnosis and Therapy	7
Social Drivers of Cancer Risk and Outcomes Among African American Men	7
Hepatocellular Carcinoma—Southeast Asia Updates	7
Treatment of Locally Recurrent Rectal Cancer	7
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	6
New Metabolomic Insights Into Cancer	6
Chimeric Antigen Receptor T-Cell Therapy	6
Neurosurgical Advances for Malignant Gliomas	6
Epidemiology and Pathogenesis of Myelodysplastic Syndrome	6
Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer	6
Ecosystemic Approach to Understanding Gut Microbiome–Mediated Prevention of Colorectal Cancer	6
Introduction	6
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	6
Combining Isocitrate Dehydrogenase Inhibitors With Existing Regimens in Acute Myeloid Leukemia	6
Microbiome and Diet in Colon Cancer Development and Treatment	6
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	6
Hormone Replacement Therapy After Breast Cancer	6
Natural Killer Cell Recognition and Control of Epithelial Cancers	6
Mechanistic Effects of Estrogens on Breast Cancer	6
Introduction Chronic Lymphocytic Leukemia. Where Do We Stand, Where Do We Go	5
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	5
PARP Inhibitors in Pancreatic Cancer	5
The Evolution of Research and Therapy With Hypomethylating Agents in Acute Myeloid Leukemia and Myelodysplastic Syndrome: New Directions for Old Drugs	5
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia	5
Management of Chronic Lymphocytic Leukemia in Less-Resourced Countries	5
Clinical Evidence Generation During a Pandemic	5
An Overview of Organoid and 3-Dimensional Models in Multiple Myeloma	5
Targeting HRAS in Head and Neck Cancer	5
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	5
Role of the Microbiome in Immunotherapy of Melanoma	5
Adoptive Cellular Therapy for Pediatric Solid Tumors: Beyond Chimeric Antigen Receptor-T Cell Therapy	5
Current State of Cell Therapies for Breast Cancer	5
From Bench to Bedside	4
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	4
Circulating Tumor DNA in Human Papillomavirus–Mediated Oropharynx Cancer	4
How Far We’ve Come	4
Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer	4
Digital Health for Oncological Care	4
Health Care Policy and Disparities in Health	4
Myelodysplastic Syndromes/Neoplasms—Insights Into Pathogenesis Leading to Improved Classification, Risk Stratification, and Treatments	4
Individualizing Therapy for Malignant Gliomas	4
Impact of Precision Medicine in Oncology	4
Telehealth in Cancer Care	4
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	4
Building a Bridge to Equity in Health and Health Care in Cancer Care	4
Menin Inhibitors in Acute Myeloid Leukemia—What Does the Future Hold?	3
From Race to Racism and Disparities to Equity	3
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer	3
The Principles and Practice of PARP Inhibitor Therapy	3

The Challenges and Future of Immunotherapy for Gliomas	3
Telehealth and Technology	3
Local and Systemic Management Options for Melanoma Brain Metastases	3
Advancements in Understanding and Preventing Obesity-Related Colon Cancer	3
Management of Low-Grade Gliomas	3
Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies	3
Introduction	3
Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment	3
Radiation Therapy and the Microbiome; More Than a Gut Feeling	3
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum	3
Development of Next-Generation Poly(ADP-Ribose) Polymerase 1–Selective Inhibitors	3
Chimeric Antigen Receptor T-Cell Therapeutics for Multiple Myeloma	3
Discovery of Natural Products for Cancer Prevention	3
Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia	2
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer	2
Telemedicine Across the Cancer Care Continuum	2
Gene Expression Profiles in Cancers and Their Therapeutic Implications	2
Using Adoptive Cellular Therapy for Localized Protein Secretion	2
Emerging Challenges to Cellular Therapy of Cancer	2
Estrogen for the Treatment and Prevention of Breast Cancer	2
Nonoperative Management for Rectal Cancer	2
Positron Emission Tomography Imaging of Tumor Proliferation and DNA Repair	2
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms	2
Effective Image Communication of Hormone Replacement Therapy Risks and Benefits	2
Cytokine Release Syndrome Biology and Management	2
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?	2
Telemedicine and Burnout—How Enhancing Operational Support Can Improve Digital Health Tools	2
The Evolving Role of Stereotactic Body Radiation Therapy in Personalized Oncologic Care	2
Overexpression of glyoxalase system enzymes in human kidney tumor: Erratum	2
Surgical Considerations for Tumor Tissue Procurement to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy	2
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma	2
Current State of Cell Therapies for Genitourinary Malignancies	2
Investigational Approaches for Treatment of Melanoma Patients Progressing After Standard of Care	2
Integrating Targeted Therapies in the Management of Head and Neck Cancers	2
Survival of the Fittest	2
Integrated, Integral, and Exploratory Biomarkers in the Development of Poly(ADP-Ribose) Polymerase Inhibitors	2
The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma	2
Melanoma—Modern Treatment for Metastatic Melanoma	2
Germline Predisposition to Myelodysplastic Syndromes	2
Current State of Stereotactic Body Radiation Therapy for Genitourinary Malignancies	2
Stereotactic Body Radiation Therapy	2
The Management of Low-Risk Myelodysplastic Syndromes—Current Standards and Recent Advances	2
Nuclear Medicine Cancer Care—Current Status and Future Directions for Radiopharmaceutical Diagnostics and Theranostics for Cancer	2
Telemedicine and Cancer Clinical Research	2
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes	2
Checkpoint Inhibitors and Other Immune-Based Therapies in Acute Myeloid Leukemia	2
Transcription Factors and Cancer	2
Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy	1
Metastatic Melanoma Treatment in Special Populations	1
Treatment of Stage III Resectable Melanoma—Adjuvant and Neoadjuvant Approaches	1
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma	1
Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development	1
Prostate Cancer, Race, and Health Disparity	1
The Evolving Molecular Landscape of High-Grade Gliomas	1
Neoantigen-Specific T Cells in Adoptive Cell Therapy	1
STING Agonists in Head and Neck Squamous Cell Carcinoma	1
Bone Metastases	1
The Evolving Role of Allogeneic Stem Cell Transplant in the Era of Molecularly Targeted Agents	1
PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy	1
Telemedicine and Cancer Care	1
The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment	1
Repurposing Drugs for Cancer Prevention	1
Current Role and Status for Intratumoral Injection Therapies in Metastatic Melanoma	1
Primary Prevention of Cancer	1
The Role of Radiolabeled Monoclonal Antibodies in Cancer Imaging and ADC Treatment	1
The Human Microbiome and Cancer	1
Updates in Risk Stratification in Myelodysplastic Syndromes	1
Menopause Hormone Therapy in the Management of Postmenopausal Osteoporosis	1
Patterns of Enrollment in Cancer Treatment Trials During the COVID-19 Pandemic at National Cancer Institute–Designated Cancer Centers	1
Optimal Management of Chronic Lymphocytic Leukemia and Economic Constraints	1
Smoldering Myeloma Treatment	1
Challenges and Errors in Genetic Testing	1
Antibody-Drug Conjugates and Tissue-Agnostic Drug Development	1
Maintenance Strategies for Myeloma	1
Clinical Targeting of Altered Metabolism in High-Grade Glioma	1
Multiple Myeloma	1
Diversity in Cancer Care	1
What Is the Timing and Role of Targeted Therapy in Metastatic Melanoma?	1
Precision Radiotherapy for Gliomas	1
γδ T Cell–Based Adoptive Cell Therapies Against Solid Epithelial Tumors	1

Antibody Drug Conjugates in Multiple Myeloma	1
Preclinical In Vitro and In Vivo Models for Adoptive Cell Therapy of Cancer	1
Coping Strategies and Their Impact on Emotional Distress and Fatigue Among Breast Cancer Survivors	1
Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute	1
Circulating Plasma Epstein-Barr Virus DNA Load During the Follow-up Periods Predicts Recurrence and Metastasis in Nasopharyngeal Carcinoma	1
The Microbiome and Liver Cancer	1